2,500 reports of this reaction
2.0% of all Ocrevus reports
#10 most reported adverse reaction
PAIN is the #10 most commonly reported adverse reaction for Ocrevus, manufactured by Genentech, Inc.. There are 2,500 FDA adverse event reports linking Ocrevus to PAIN. This represents approximately 2.0% of all 124,640 adverse event reports for this drug.
Patients taking Ocrevus who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is a less commonly reported adverse event for Ocrevus, but still significant enough to appear in the safety profile.
In addition to pain, the following adverse reactions have been reported for Ocrevus:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 2,500 FDA reports for Ocrevus. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 2.0% of all adverse event reports for Ocrevus, making it a notable side effect.
If you experience pain while taking Ocrevus, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.